Featured Products

• Netarsudil(Mesylate) (Catalog# : 712181, Cas# : 1422144-42-0) Netarsudil, also known as AR-11324, is a Rho-associated protein kinase inhibitor. Netarsudil is potential useful for treating glaucoma and​/or reducing intraocular pressure. Neta
• Entrectinib(RXDX-101) (Catalog# : 100504, Cas# : 1108743-60-7) Entrectinib (RXDX-101) is a selective inhibitor for all three TRK receptor tyrosine kinases encoded by the three NTRK genes, as well as the ROS1 and ALK receptor tyrosine kinases.
• JPH203 HCl (Catalog# : 18381, Cas# : 1597402-27-1) JPH203, also known as KYT-0353, is a potent and selective LAT1 selective ( L-type amino acid transporter 1) inhibitor. JPH203 can very potently inhibit l-leucine uptake.
• ARRY-797 (ARRY-371797) (Catalog# : 191112, Cas# : 1036404-17-7) NEWARRY-797 (ARRY-371797) is an oral, selective p38 mitogen-activated protein kinase inhibitor.
• lumateperone(Tosylate) (Catalog# : 17012102, Cas# : 1187020-80-9) Lumateperone (ITI-722/ITI-007) is a novel, first-in-class dual 5HT2A receptor antagonist/dopamine phosphoprotein modulator (DPPM) for schizophrenia. It is an orally available com
• SCR7 pyrazine (Catalog# : 1712261, Cas# : 14892-97-8) NEWSCR7 pyrazine is a small molecule inhibitor of DNA ligase IV that prevents nonhomologous end-joining by interfering with ligase binding and activating apoptosis.
• eCF506 (Catalog# : 18382, Cas# : 1914078-41-3) eCF506 targets a molecule called Src tyrosine kinase that is required for breast cancer cells to grow and spread. eCF506 may be highly effective at blocking growth of breast canc
• Esaxerenone (Catalog# : 1710121, Cas# : 1632006-28-0) Esaxerenone (INN) (developmental code names CS-3150, XL-550) is a nonsteroidal antimineralocorticoid which was discovered by Exelixis and is now under development by Daiichi Sank
• BMS-777607 (Catalog# : 121417, Cas# : 1025720-94-8; 1196681-44-3) NEWBMS-777607 is an inhibitor of MET tyrosine kinase with potential antineoplastic activity. MET tyrosine kinase inhibitor BMS-777607 binds to c-Met protein, or hepatocyte growth fa
• Copanlisib HCI (Catalog# : 18351, Cas# : 1402152-13-9) Copanlisib also known as BAY 80-6946, is a potent phosphoinositide 3-kinase (PI3K) inhibitor. Copanlisib inhibits the activation of the PI3K signaling pathway, which may result i
• Nelotanserin (Catalog# : 191121, Cas# : 839713-36-9) Nelotanserin(APD125) is a potent and selective human 5-hydroxytryptamine2A inverse agonist for the treatment of insomnia.
• Cenicriviroc (Catalog# : 179139, Cas# : 497223-25-3) Cenicriviroc (code names TAK-652, TBR-652) is an experimental drug candidate for the treatment of HIV infection.
• PTI-428(PTI428) (Catalog# : 193211, Cas# : 1953130-87-4) NEWTI-428 is an investigational CFTR amplifier in development for the treatment of CF in patients who are homozygous for the F508del mutation in the CFTR gene as an add-on therapy t
• WWL70 (Catalog# : 16122847, Cas# : 947669-91-2) WWL70 is selective ABHD6 inhibitor, and it has shown anti-inflammatory and neuroprotective effects in animal models of traumatic brain injury and multiple sclerosis.
• Elenbecestat(E2609) (Catalog# : 2017878, Cas# : 1388149-30-1) NEWElenbecestat,also known as E2609 is a BACE1 inhibitor. 
• VU0467154 (Catalog# : 18576, Cas# : 1451993-15-9) NEWVU0467154 is a potent and selective M4 PAM.
• Tafenoquine (Catalog# : 191122, Cas# : 106635-80-7) NEWTafenoquine is being investigated as a potential treatment for malaria, as well as for malaria prevention.
• KI-696 (Catalog# : 1710132, Cas# : 1799974-70-1) KI-696 represents an excellent LMW tool to study the KEAP1-NRF2 interaction in vivo. Discovered by FBS, the probe is well characterised in a number of in vitro assays as well as
• L-778123 (Catalog# : 1711249, Cas# : 183499-57-2) L-778,123 is an inhibitor of FPTase and GGPTase-I.
• Tafenoquine succinate (Catalog# : 191123, Cas# : 106635-81-8) Tafenoquine is being investigated as a potential treatment for malaria, as well as for malaria prevention.
• MORE  >>